Minor
D2C7-IT With Atezolizumab for Recurrent Gliomas
Trial completed
Also in this update: Final enrollment: 14 participants (planned 18); Study completion date changed from estimate of Dec 2027 to Jun 11, 2026
Darell BignerPhase 1 NCT04160494 Registry history of NCT04160494 on ClinicalTrials.gov (opens the registry)